Top

Published in:

01-10-2016 | Editorial

Paving the road for the study of epigenetics in neurodegenerative diseases

Published in: Acta Neuropathologica | Issue 4/2016

Excerpt

Neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS), are among the most challenging health problems that still remain with no treatment. This becomes especially important in developed countries with an increasing population age. These diseases are characterized by progressive neuronal death, and aging is one of the most important risk factors. Currently, there are no effective treatments for any of these diseases, and the burden they cause, with incalculable economic and human costs, is growing inexorably as the population ages. …

Belzil VV, Katzman RB, Petrucelli L (2016) ALS and FTD: an epigenetic perspective. Acta Neuropathol. doi:10.1007/s00401-016-1587-4 PubMed

De Jager PL, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, Eaton ML, Keenan BT, Ernst J, McCabe C et al (2014) Alzheimer’s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci 17:1156–1163. doi:10.1038/nn.3786 CrossRefPubMedPubMedCentral

Dejesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245–256. doi:10.1016/j.neuron.2011.09.011 CrossRefPubMedPubMedCentral

DeVos SL, Miller TM (2013) Antisense oligonucleotides: treating neurodegeneration at the level of RNA. Neurotherapeutics 10:486–497. doi:10.1007/s13311-013-0194-5 CrossRefPubMedPubMedCentral

Horvath S (2013) DNA methylation age of human tissues and cell types. Genome Biol 14:R115. doi:10.1186/gb-2013-14-10-r115 CrossRefPubMedPubMedCentral

Klein HU, Bennet AD, De Jager P (2016) The epigenome in Alzheimer’s disease: a new path to discovery and mechanism. Acta Neuropathol. doi:10.1007/s00401-016-1612-7 PubMedCentral

Labbe C, Lorenzo-Betancor O, Ross OA (2016) Epigenetic regulation in Parkinson’s disease. Acta Neuropathol. doi:10.1007/s00401-016-1590-9 PubMed

Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, Jun G, Destefano AL, Bis JC, Beecham GW et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet. doi:10.1038/ng.2802

Lord J, Cruchaga C (2014) The epigenetic landscape of Alzheimer’s disease. Nat Neurosci 17:1138–1140. doi:10.1038/nn.3792 CrossRefPubMed

10.

Lunnon K, Smith R, Volta M, Troakes C, Mill J (2014) Cross-tissue methylomic profiling in Alzheimer’s disease implicates a role for cortex-specific deregulation of ANK1 in neuropathology. Nat Neurosci 17:1164–1170CrossRefPubMedPubMedCentral

11.

Miller TM, Pestronk A, David W, Rothstein J, Simpson E, Appel SH, Andres PL, Mahoney K, Allred P, Alexander K et al (2013) An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol 12:435–442. doi:10.1016/S1474-4422(13)70061-9 CrossRefPubMedPubMedCentral

12.

Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M et al (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet 46:989–993. doi:10.1038/ng.3043 CrossRefPubMedPubMedCentral

13.

Pottier C, Ravenscroft TA, Sanchez-Contreras M, Rademakers R (2016) Genetics of FTLD: overview and what else we can expect from genetic studies. J Neurochem 138(Suppl 1):32–53. doi:10.1111/jnc.13622 CrossRefPubMed

14.

Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257–268. doi:10.1016/j.neuron.2011.09.010 CrossRefPubMedPubMedCentral

15.

Robertson KD (2005) DNA methylation and human disease. Nat Rev Genet 6:597–610. doi:10.1038/nrg1655 CrossRefPubMed

16.

Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M et al (2010) Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet 42:234–239. doi:10.1038/ng.536 CrossRefPubMedPubMedCentral

Title: Paving the road for the study of epigenetics in neurodegenerative diseases
Publication date: 01-10-2016
Published in: Acta Neuropathologica / Issue 4/2016
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-016-1614-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Paving the road for the study of epigenetics in neurodegenerative diseases

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2016

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort

Neuropathological criteria of anti-IgLON5-related tauopathy

Human-to-mouse prion-like propagation of mutant huntingtin protein

Epigenetic regulation in Parkinson’s disease

The phosphatase calcineurin regulates pathological TDP-43 phosphorylation

The epigenome in Alzheimer’s disease: current state and approaches for a new path to gene discovery and understanding disease mechanism